news
The Indian government's BioE3 policy outlines a strategic framework to advance high-performance biomanufacturing, identifying key thematic areas like biobased chemicals, precision therapeutics, and carbon capture. Led by the Ministry of Science and Technology and Biotechnology Research Assistance Council, proposals are encouraged for projects that enhance biomanufacturing and Biofoundry
news
The Government of India has introduced the BioE3 Policy to propel biomanufacturing by adopting advanced technologies and fostering research in high-value bio-based products. The policy focuses on six critical areas including biopolymers, smart proteins, and precision biotherapeutics, and promotes the development of state-of-the-art facilities like Biofoundries and Bio-AI Hubs. Experiments
news
India is advancing its gene and biotech frameworks to support safe and ethical development of gene-editing therapies such as CRISPR. The regulatory bodies CDSCO, ICMR, and DBT have introduced guidelines for gene therapy product development, while initiatives like the BioE3 Policy aim to enhance the country's biomanufacturing capabilities.
news
The Ministry of Science & Technology, along with the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC), recently hosted a prestigious national event to kickstart biomanufacturing projects focused on carbon capture and utilization (CCU) in New Delhi. This initiative aligns with India's BioE3 Policy,
news
India's Ministry of Science & Technology has introduced the BioE3 Policy to enhance the country's biomanufacturing capabilities through cutting-edge technologies and innovative research. The policy focuses on accelerating biomanufacturing in six main sectors, including bio-based chemicals, functional foods, and climate-resilient agriculture. It promotes innovation and entrepreneurship
Healthcare
At the Bengaluru Diabetes Conference, Union Minister Dr. Jitendra Singh urged the healthcare sector to reduce reliance on government funding and foster private sector involvement. He highlighted India's advancements in biomanufacturing, indigenous medical devices, and successful research initiatives, emphasizing the need for collaboration between academia and industry to
Biomanufacturing
Union Minister Dr. Jitendra Singh announced the launch of 21 new BioEnabler facilities under the BioE3 policy, positioning India as a global leader in biomanufacturing. The initiative aims to enhance self-reliance, reduce import dependence, and drive innovation in biotechnology, with the bioeconomy projected to grow from $100 billion to $300
Biomanufacturing
Union Minister Dr. Jitendra Singh announced that India now hosts 21 out of 121 bio-companies worldwide, marking a significant achievement in biomanufacturing. The launch of 21 new BioEnabler facilities aims to position India as a global hub for biotechnology, driving self-reliance, job creation, and reduced import dependence. The initiative is
Bioeconomy
Union Minister Dr. Jitendra Singh announced that India's bioeconomy is projected to grow from $165.7 billion in 2024 to $300 billion by 2030, marking the one-year anniversary of the BioE3 Policy. The initiative includes the launch of the BioE3 Challenge for Youth and the National Biofoundry Network
BioE3 Policy
During a joint review of Science Ministries, Dr. Jitendra Singh highlighted India's BioE3 Policy, aimed at establishing the country as a global biomanufacturing hub. The policy integrates biotechnology with AI and has received over 2,000 proposals in its first round. Key focus areas include carbon capture, precision
ISRO
The first ISRO-DBT Joint Working Group (JWG) meeting was held on May 28, 2025, focusing on collaboration in space biotechnology and biomanufacturing. This meeting follows a Memorandum of Understanding signed in October 2024 and aims to advance initiatives under the BioE3 policy, which promotes biotechnology for economic, environmental, and employment